1. Home
  2. AUPH vs LOT Comparison

AUPH vs LOT Comparison

Compare AUPH & LOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • LOT
  • Stock Information
  • Founded
  • AUPH 1993
  • LOT 1948
  • Country
  • AUPH Canada
  • LOT China
  • Employees
  • AUPH N/A
  • LOT N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • LOT
  • Sector
  • AUPH Health Care
  • LOT
  • Exchange
  • AUPH Nasdaq
  • LOT NYSE
  • Market Cap
  • AUPH 1.1B
  • LOT 956.3M
  • IPO Year
  • AUPH 1999
  • LOT N/A
  • Fundamental
  • Price
  • AUPH $8.77
  • LOT $2.24
  • Analyst Decision
  • AUPH Strong Buy
  • LOT
  • Analyst Count
  • AUPH 2
  • LOT 0
  • Target Price
  • AUPH $11.50
  • LOT N/A
  • AVG Volume (30 Days)
  • AUPH 1.4M
  • LOT 70.6K
  • Earning Date
  • AUPH 07-31-2025
  • LOT 06-25-2025
  • Dividend Yield
  • AUPH N/A
  • LOT N/A
  • EPS Growth
  • AUPH N/A
  • LOT N/A
  • EPS
  • AUPH 0.27
  • LOT N/A
  • Revenue
  • AUPH $247,295,000.00
  • LOT $844,090,000.00
  • Revenue This Year
  • AUPH $12.15
  • LOT $40.53
  • Revenue Next Year
  • AUPH $18.31
  • LOT $87.99
  • P/E Ratio
  • AUPH $31.76
  • LOT N/A
  • Revenue Growth
  • AUPH 29.20
  • LOT 1.33
  • 52 Week Low
  • AUPH $5.20
  • LOT $1.06
  • 52 Week High
  • AUPH $10.67
  • LOT $7.42
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 66.00
  • LOT 58.83
  • Support Level
  • AUPH $7.71
  • LOT $2.02
  • Resistance Level
  • AUPH $8.29
  • LOT $2.75
  • Average True Range (ATR)
  • AUPH 0.25
  • LOT 0.14
  • MACD
  • AUPH 0.03
  • LOT 0.01
  • Stochastic Oscillator
  • AUPH 84.40
  • LOT 40.30

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About LOT LOTUS TECHNOLOGY INC

Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.

Share on Social Networks: